C-Mer Proto-Oncogene Tyrosine Kinase (MERTK) Peptid
MERTK
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle MERTK Produkte
- MERTK (C-Mer Proto-Oncogene Tyrosine Kinase (MERTK))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- MERTK peptide corresponds to 10 amino acids of MERTK.
-
C-Mer Proto-Oncogene Tyrosine Kinase (MERTK) peptide
MERTK Reaktivität: Human Wirt: Synthetic BP, Imm
-
- Applikationshinweise
- MERTK Peptide is used for blocking the activity of MERTK antibody . The MERTK antibody ships at 0.5 mg/mL and the MERTK Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- MERTK peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- MERTK (C-Mer Proto-Oncogene Tyrosine Kinase (MERTK))
- Synonyme
- MER Peptide, RP38 Peptide, c-mer Peptide, Eyk Peptide, Mer Peptide, Nyk Peptide, nmf12 Peptide, rdy Peptide, C-EYK Peptide, MERTK Peptide, DKFZp469D2215 Peptide, si:ch1073-268l12.2 Peptide, MER proto-oncogene, tyrosine kinase Peptide, c-mer proto-oncogene tyrosine kinase Peptide, c-mer proto-oncogene tyrosine kinase a Peptide, MERTK Peptide, Mertk Peptide, mertka Peptide
- Gen-ID
- 10461
- NCBI Accession
- NP_006334
- OMIM
- 66932918
- UniProt
- Q12866
-
Sie sind hier:
